Truist Financial Maintains Autolus Therapeutics(AUTL.US) With Buy Rating

Futu NewsJan 23 20:33 · Ratings

Autolus Therapeutics (AUTL) Gets a Buy From Truist Financial

TipRanksJan 23 20:26 · Ratings

Autolus Therapeutics to Present Key Data on AUCATZYL At 2025 Tandem Meetings, Highlighting Cost Benefits and Clinical Outcomes

BenzingaJan 17 20:12

Wells Fargo Maintains Autolus Therapeutics(AUTL.US) With Buy Rating, Maintains Target Price $8

Futu NewsJan 14 18:33 · Ratings

Positive Buy Rating for Autolus Therapeutics Driven by Aucatzyl's Promising Launch and Strategic Growth Prospects

TipRanksJan 14 17:58 · Ratings

Autolus Reports FDA Approval and NCCN Inclusion of AUCATZYL, Sets Milestones for Pipeline Growth

BenzingaJan 13 21:25